You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨騰盛博藥(02137.HK)大漲超15%破頂 新冠中和抗體試驗顯示對Delta病毒有效
格隆匯 08-06 10:02
格隆匯8月6日丨騰盛博藥(02137.HK)大幅拉昇漲超15%,報28.55港元創歷史新高價,總市值站上200億港元大關。騰盛博藥5日宣佈,其新冠中和抗體已完成美國三期臨牀試驗的846病人的入組,臨牀前毒理實驗顯示對Delta病毒有效。若後續數據積極,將會有被用於EUA的可能性,這也將是中國唯一一個獲批的中和抗體。公司已與中國政府機構及醫院開展合作,向廣州、深圳、瑞麗、昆明、南京以及揚州提供BRII-196/BRII-198開展緊急救治,積極配合中國政府進行緊急支援。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account